Bristol Myers Squibb

OPDIVO - Cost

Last Updated: April 1st, 2024

HCPCS:

J9299

HCPCS Code Descriptor:

Injection, nivolumab, 1 mg

Medicare Payment Limit:

The OPDIVO Medicare Payment Limit is $31.094

Average Sale Price:

OPDIVO ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The OPDIVO Medicare Co-insurance percentage is 20%. OPDIVO's Medicare Co-insurance amount is $6.22 per HCPCS unit.

APC Code:

The Opdivo APC Code is: 9453

APC Payment Limit:

The APC Payment Limit for OPDIVO is available. Login to view.

Opdivo Cost Information:

OPDIVO is manufactured by Bristol Myers Squibb and is associated with HCPCS J9299. OPDIVO became effective on January 1, 2016 and has four NDCs aligned to J9299. Historical pricing indicates a steady increase of a few percentage points every six months. Overall, AWP and WAC have increased by nearly 28% and ASP by an estimated 25% from its inception.

ACCESS PRICING AND MORE BY REGISTERING

Opdivo’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Opdivo’s average wholesale price (AWP) information was last updated on:
January 1, 2024

Opdivo Cost Graph: